ABSENOR

This brand name is authorized in Finland, Lithuania, Poland.

Active ingredients

The drug ABSENOR contains one active pharmaceutical ingredient (API):

1	Valproic acid UNII 5VOM6GYJ0D - VALPROATE SODIUM
	Valproic acid is anti-convulsant. The most likely mode of action for valproate is potentiation of the inhibitory action of gamma amino butyric acid (GABA) through an action on the further synthesis or further metabolism of GABA.
	Read more about Valproic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N03AG01	Valproic acid	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AG Fatty acid derivatives
Discover more medicines within N03AG01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FI	Lääkealan turvallisuus- ja kehittämiskeskus	007097, 007111, 007134, 106609, 106617, 120535, 469395
LT	Valstybinė vaistų kontrolės tarnyba	1004788
PL	Rejestru Produktów Leczniczych	100168073, 100168989